|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of incisional hernia.It was reported that after implant, the patient experienced recurrence, pain, adhesions, bulging, abdominal wall fluid collection, inflammation, infection, scarring, nerve damage, mental pain, suffering, disability, permanent impairment, loss of enjoyment of life, serosanguinous fluid, abdominal pain, & oozing.Post-operative patient treatment included revision surgery, hernia repair with mesh, incisional hernia repair, ct scan, ct guided aspiration of fluid collection, pain medication, component separation, diagnostic lap, & lysis of adhesions.
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|